Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
Open Access
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (3) , 281-288
- https://doi.org/10.1023/a:1008399414923
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Analysis of failures in patients with stage I ovarian cancer: an Italian multicenter studyInternational Journal of Gynecologic Cancer, 1997
- Natural history and prognosis of untreated stage I epithelial ovarian carcinoma.Journal of Clinical Oncology, 1996
- Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapseAmerican Journal of Obstetrics and Gynecology, 1993
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993
- Cancer statistics, 1993CA: A Cancer Journal for Clinicians, 1993
- Is Stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five‐year cancer registry reviewBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Prognostic significance of histologic classification and grading of epithelial malignancies of the ovaryAmerican Journal of Obstetrics and Gynecology, 1984
- A study of 656 patients with “early” ovarian cancerGynecologic Oncology, 1984
- Prognostic factors in malignant epithelial ovarian tumorsGynecologic Oncology, 1983
- Disagreement of histopathological diagnoses of different pathologists in ovarian tumors — with some theoretical considerationsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1982